T-cell genetic modification for re-directed tumor recognition.

Laurence J.N. Cooper; Michael Kalos; David DiGiusto; Christine Brown; Stephen J. Forman; Andrew Raubitschek; Michael C. Jensen

doi:10.1016/s0921-4410(04)22014-2

T-cell genetic modification for re-directed tumor recognition.

Laurence J.N. Cooper, Michael Kalos, David DiGiusto, Christine Brown, Stephen J. Forman, Andrew Raubitschek, Michael C. Jensen

Pediatrics

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Original language	English (US)
Pages (from-to)	293-324
Number of pages	32
Journal	Cancer chemotherapy and biological response modifiers
Volume	22
DOIs	https://doi.org/10.1016/s0921-4410(04)22014-2
State	Published - 2005

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/s0921-4410(04)22014-2

Cite this

@article{56adc55fe3574d05a662df8faaf606fa,

title = "T-cell genetic modification for re-directed tumor recognition.",

author = "Cooper, {Laurence J.N.} and Michael Kalos and David DiGiusto and Christine Brown and Forman, {Stephen J.} and Andrew Raubitschek and Jensen, {Michael C.}",

year = "2005",

doi = "10.1016/s0921-4410(04)22014-2",

language = "English (US)",

volume = "22",

pages = "293--324",

journal = "Cancer chemotherapy and biological response modifiers",

issn = "0921-4410",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - T-cell genetic modification for re-directed tumor recognition.

AU - Cooper, Laurence J.N.

AU - Kalos, Michael

AU - DiGiusto, David

AU - Brown, Christine

AU - Forman, Stephen J.

AU - Raubitschek, Andrew

AU - Jensen, Michael C.

PY - 2005

Y1 - 2005

UR - http://www.scopus.com/inward/record.url?scp=25444497299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444497299&partnerID=8YFLogxK

U2 - 10.1016/s0921-4410(04)22014-2

DO - 10.1016/s0921-4410(04)22014-2

M3 - Review article

C2 - 16110618

AN - SCOPUS:25444497299

SN - 0921-4410

VL - 22

SP - 293

EP - 324

JO - Cancer chemotherapy and biological response modifiers

JF - Cancer chemotherapy and biological response modifiers

ER -

T-cell genetic modification for re-directed tumor recognition.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this